|Document ID (ISN)||108349|
|Convention or series no.
Agency for Toxic Substances and Disease Registry (ATSDR)
||Toxicological profile for lead (Update)
||U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Division of Toxicology/Toxicology Information Branch, 1600 Clifton Road NE, E-29, Atlanta, GA 30333, USA, Aug. 2007. xx, 528p. Illus. Approx. 1700 ref. Index.
||http://www.atsdr.cdc.gov/toxprofiles/tp13.pdf [in English]
08-0768.pdf [in English]
||This profile has been prepared in accordance with guidelines set by the US Agency for Toxic Substances and Disease Registry and the EPA. The key literature related to the toxic effects of lead is identified and reviewed. Contents: public health statement; health effects; chemical and physical information; production, import, use and disposal; potential for human exposure; analytical methods; regulations and advisories; glossary. Health hazards include: brain damage (neurotoxic effects, encephalopathy); renal damage; haematotoxic effects (anaemia); damage to the male reproductive system; retarded development of newborn children. IARC classifies organic lead compounds as possible human carcinogens (group 2B), while inorganic lead compounds are not classifiable with respect to their human carcinogenicity because of insufficient evidence. (Update of CIS 96-2227).
||USA; lead and compounds; health hazards; toxicology; toxicity evaluation; lead
||toxic effects; criteria document; literature survey; antifertility effects; children; IARC; anaemia; encephalopathy; brain tissue damage; renal damage; limitation of exposure; exposure evaluation; teratogenic effects; haematotoxic effects; glossary; neurotoxic effects
||B - Chemical safety information sheets
|Country / State or Province||USA|
||Toxic and dangerous substances
|Broad subject area(s)
Genetic factors in reaction to exposures
Lead and compounds